Abstract
Necrotizing enterocolitis (NEC) is the most common acquired gastrointestinal disease in premature infants. The molecular basis of this multifactorial disease is poorly understood, and NEC diagnosis and treatment strategies still remain difficult and challenging. In current research, preventive approaches are of the utmost priority. Providing human milk to premature infants has been shown to be an effective intervention that decreases the incidence of NEC. Interestingly, recent reports reveal that l-arginine supplementation may be a promising prevention modality of NEC by promoting nitric oxide (NO) synthesis. Deficient or inadequate NO levels due to l-arginine deficiency or immaturity of NO synthase (NOS) activity in premature infants may lead to vasoconstriction and ischemia–reperfusion injury and may predispose the neonates to develop NEC. The role of l-arginine supplementation in NEC has been highlighted in numerous studies on experimental animal models and human neonates. These researches reveal that the prophylactic administration of l-arginine in low doses is safe with no adverse effects for the premature neonates and also that l-arginine supplementation appears to be effective in reducing the overall incidence of NEC in preterm infants and especially the incidence of Bell’s stage III NEC. The recent evidence on the l-arginine role in NEC pathophysiology opens up a new area in the field of NEC prevention and further supports the essential role of amino acids in nutrition and disease prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blakely ML, Lally KP, McDonald S, et al. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD neonatal research network. Ann Surg. 2005;241(6):984–9. discussion 989–994.
Srinivasan PS, Brandler MD, D’Souza A. Necrotizing enterocolitis. Clin Perinatol. 2008;35(1):251–72.
Lodha A, Asztalos E, Moore AM. Cytokine levels in neonatal necrotizing enterocolitis and long-term growth and neurodevelopment. Acta Paediatr. 2010;99:338–43.
Martin CR, Dammann O, Allred EN, et al. Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia. J Pediatr. 2010;157:751–6.
Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368:1271–83.
Davey AM, Wagner CL, Cox C. Feeding premature infants while low umbilical artery catheters are in place: a prospective, randomized trial. J Pediatr. 1994;124:795–9.
Moss RL, Kalish LA, Duggan C, et al. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multiinstitutional study. J Perinatol. 2008;28:665–74.
Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr. 2005;94(Suppl):100–5.
Blau J, Calo JM, Dozor D, et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr. 2011;158:403–9.
Llanos AR, Moss ME, Pinzòn MC, et al. Epidemiology of neonatal necrotising enterocolitis: a population based study. Paediatr Perinat Epidemiol. 2002;16:342–9.
Martinez-Tallo E, Claure N, Bancalari E. Necrotizing enterocolitis in full-term or near-term infants: risk factors. Biol Neonate. 1997;71:292–8.
Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone treatment in extremely-low-birth- weight infants. N Engl J Med. 2001;344:95–101.
Attridge JT, Clark R, Walker MW, et al. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol. 2006;26:93–9.
Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.
Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179–201.
Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am. 1996;43(2):409–32.
Alfaleh K, Anabrees J, Bassler D, et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011;3:CD005496.
Modi N, Uthaya S, Fell J, et al. A randomized, double blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690). Pediatr Res. 2010;68:440–5.
Underwood MA, Salzman NH, Bennett SH, et al. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr. 2009;48:216–25.
Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990;336:1519–23.
Wu G, Bazer FW, Davis TA, et al. l-Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153–68.
Zamora SA, Amin HJ, McMillan DD, et al. Plasma l-arginine concentration, oxygenation index, and systemic blood pressure in premature infants. Crit Care Med. 1998;26:1271–6.
Kohler ES, Sankaranarayanan S, van Ginneken CJ, et al. The human neonatal small intestine has the potential for l-arginine synthesis; developmental changes in the expression of l-arginine-synthesizing and -catabolizing enzymes. BMC Dev Biol. 2008;8:107.
Wu G, Jaeger LA, Bazer FW, et al. l-Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem. 2004;15(8):442–51.
Batshaw ML. Long term treatment of inborn errors of urea synthesis. In: Kleinberger G, editor. Advances in hepatic encephalopathy and urea cycle diseases. Basel: Karger; 1984. p. 187–95.
Wu G, Bazer FW, Tou W. Developmental changes of free amino acid concentrations in fetal fluids of pigs. J Nutr. 1995;125:2859–68.
Snyderman SEHL, Norton PM, et al. Protein requirements of the premature infant. II. Influence of protein intake on free amino acid content of plasma and red blood cells. Am J Clin Nutr. 1970;23:890–5.
Zamora SA, Amin HJ, McMillan DD, et al. Plasma l-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr Gastroenterol Nutr. 1997;131:226–32.
Van Goudoever JB, Colen T, Wattimenta JLD, et al. Immediate commencement of amino acid supplementation in preterm infants: effect on serum amino acid concentrations and protein kinetics on the first day of life. J Pediatr. 1995;127:458–65.
Wu PY, Edwards N, Storm MC. Plasma amino acid patterns in normal term breast-fed infants. J Pediatr. 1986;109:347–9.
Wu G, Knabe DA. Free and protein-bound amino acids in sow’s colostrum and milk. J Nutr. 1994;124:415–24.
Becker RM, Wu G, Galanko JA, et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr. 2000;137:785–93.
Ventura V, Brooke OG. Plasma amino acids in small preterm infants fed on human milk or formula. Arch Dis Child. 1987;62:1257–64.
Heird WC, Driscoll JM, Schullinger JN, et al. Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic L-amino acids: a preliminary report. J Pediatr. 1972;81:162–5.
Batshaw ML, Bursilow SW. Asymptomatic hyperammonemia in low-birth weight infants. Pediatr Res. 1978;12:221–4.
Srinivasan G, Amin A, Pildes RS, et al. Plasma amino acid patterns in very low birth weight infants during parenteral nutrition. Indian J Pediatr. 1990;57:93–7.
Thomas DW, Sinatra FR, Hack SL, et al. Hyperammonemia in neonates receiving intravenous nutrition. J Parenter Enteral Nutr. 1982;6:503–6.
Ball RH, Wykes LL, Pencharz PB, et al. A piglet model for neonatal amino acid metabolism during total parenteral nutrition. New York: Plenum Press; 1996.
Amin HJ, Zamora SA, McMillan DD, et al. l-Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr Gastroenterol Nutr. 2002;140:425–31.
McCaffrey MJ, Bose CL, Reiter PD, et al. Effects of l-arginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate. 1995;67:240–3.
Brunton JA, Bertolo RF, Pencharz PB, et al. Proline ameliorates l-arginine deficiency during enteral but not parenteral feeding in neonatal piglets. Am J Physiol Endocrinol Metab. 1999;277:223–31.
Wu G, Meininger CJ, Knabe DA, et al. l-Arginine nutrition in development, health and disease. Curr Opin Clin Nutr Metab Care. 2000;3:59–66.
Richir MC, Siroen MP, van Elburg RM, et al. Low plasma concentrations of l-arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis. Br J Nutr. 2007;97:906–11.
Cintra AE, Martins JL, Patrício FR, et al. Nitric oxide levels in the intestines of mice submitted to ischemia and reperfusion: l-arginine effects. Transplant Proc. 2008;40:830–5.
Fukatsu K, Ueno C, Maeshima Y, et al. Effects of l-arginine infusion during ischemia on gut blood perfusion, oxygen tension, and circulating myeloid cell activation in a murine gut ischemia/reperfusion model. J Parenter Enteral Nutr. 2004;4:224–30.
Nankervis CA, Giannone PJ, Reber KM. The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. Semin Perinatol. 2008;32:83–91.
Milakofsky L, Harris N, Vogel WH. Effects of repeated stress on plasma l-arginine levels in young and old rats. Physiol Behav. 1993;54:725–8.
Clark DA, Thompson JE, Weiner LB, et al. Necrotizing enterocolitis: intraluminal biochemistry in human neonate and a rabbit model. Pediatr Res. 1985;19:919–21.
Di Lorenzo M, Bass J, Krantis A. Use of l-arginine in the treatment of experimental necrotizing enterocolitis. J Pediatr Surg. 1995;30(2):235–40.
Akisu M, Ozmen D, Baka M, et al. Protective effect of dietary supplementation with l-arginine and L-carnitine on hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Biol Neonate. 2002;81:260–5.
Kul M, Vurucu S, Demirkaya E, et al. Enteral glutamine and/or l-arginine supplementation have favorable effects on oxidative stress parameters in neonatal rat intestine. J Pediatr Gastroenterol Nutr. 2009;49:85–9.
Cekmez F, Purtuloğlu T, Aydemir G, et al. Comparing beneficial effects of inhaled nitric oxide to l-arginine in necrotizing enterocolitis model in neonatal rats. Pediatr Surg Int. 2012;28:1219–24.
Polycarpou E, Zachaki S, Tsolia M, et al. Enteral l-arginine supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: a double-blind randomized pilot study of efficacy and safety. J Parenter Enteral Nutr. 2013;37(5):617–22.
Neu J. l-Arginine supplementation for neonatal necrotizing enterocolitis: are we ready? Br J Nutr. 2007;97:814–5.
Group UCDC. Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr Gastroenterol Nutr. 2001;138(Suppl):S1–5.
Wu G, Bazer FW, Cudd TA, et al. Pharmacokinetics and safety of l-arginine supplementation in animals. J Nutr Biochem. 2007;137(6 Suppl 2):1673S–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zachaki, S., Gavrili, S., Polycarpou, E., Hatzi, V.I. (2017). Enteral l-Arginine and Necrotizing Enterocolitis. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-26009-9_30
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-26007-5
Online ISBN: 978-3-319-26009-9
eBook Packages: MedicineMedicine (R0)